Anakinra drug data and news

---

1 From the Department of Medicine, Division of Infectious Diseases ...  Feb 14, 2006
Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. ... Anakinra for flares of pyogenic arthritis in PAPA syndrome. ... - Am J Clin Nutr (subscription),

NPS Pharmaceuticals Reports Fourth Quarter and Year-End Operating ...  Feb 16, 2006
...marketing authorization application (MAA) in Europe; * Building a commercial sales organization to promote partnered products Kineret(R) (anakinra) and Restasis ... - MSN Money

Rheumatic Diseases Remain a Significant Cause of Chronic Illness ...  Feb 22, 2006
Kineret (anakinra) the only IL-1 inhibitor currently available does not appear to be in development for JIA, but Actemra (tocilizumab) is expected to launch in ... - Business Wire (press release),

Better Fix For Rheumatoid Arthritis  Feb 16, 2006
...which contribute to inflammation. Examples are etanercept, infliximab, adalimumab and anakinra. • Protein-A Immunoadsorption Therapy ... - WFtv.com,

American Journal of Clinical Nutrition, Vol. 83, No. 2, 475S-483S ...  Feb 17, 2006
...the activity of either TNF- [etanercept (Enbrel; Amgen, Thousand Oaks, CA); infliximab (Remicade; Centocor, Horsham, PA)] or IL-1 [anakinra (Kineret; Amgen ... - Am J Clin Nutr (subscription),

NPS Pharmaceuticals Reports Fourth Quarter and Year-End Operating ...  Feb 16, 2006
...primarily due to increased marketing and commercial activities associated with PREOS(R), costs related to the promotion of Kineret(R) (anakinra), a biologic ... - PharmaLive.com (press release),

Better Fix for Rheumatoid Arthritis  Feb 1, 2006
...which contribute to inflammation. Examples are etanercept, infliximab, adalimumab and anakinra. Protein-A Immunoadsorption Therapy ... - ABC7Chicago.com,

HUMIRA(R) (Adalimumab) Shows Promise in Treating Patients With ...  Nov 13, 2005
Treatment with HUMIRA should not be initiated in patients with active infections. The combination of HUMIRA and anakinra is not recommended. ... - PR Newswire (press release),

HUMIRA (Adalimumab) Receives FDA Approval for Treatment of ...  Oct 4, 2005
Treatment with HUMIRA should not be initiated in patients with active infections. The combination of HUMIRA and anakinra is not recommended. ... - PharmaLive.com (press release),

Psoriatic arthritis, FDA approves Humira for reducing signs and ...  Oct 5, 2005
Treatment with Humira should not be initiated in patients with active infections. The combination of Humira and Kineret ( Anakinra ) is not recommended. ... - Xagena.it,

Era of molecular biology has been boon to rheumatologists  Oct 3, 2005
Anakinra is a recombinant form of the IL-1 receptor antagonist, the naturally occurring inhibitor of IL-1. This agent, approved for use in adult RA, has shown ... - AAP News (subscription)

Xoma names new vice president  Jul 28, 2005
At Amgen, he helped design the clinical and commercial strategies for marketed products Enbrel (Etanercept) and Kineret (Anakinra) and other late-stage products ... - East Bay Business Times

XOMA Appoints Alan M. Solinger, MD as Vice President of Clinical ...  Jul 28, 2005
Amgen, he participated in the design of the clinical and commercial strategies for marketed products Enbrel(R) (Etanercept) and Kineret(R) (Anakinra), and for ... - Business Wire (press release)

Treating RA: Recent Evidence from the European League Against ...  Jul 25, 2005
These findings showing a greater infection risk are comparable to that previously reported with combination etanercept/anakinra. ... - Medscape (subscription)

Xoma names new vice president  Jul 28, 2005
At Amgen, he helped design the clinical and commercial strategies for marketed products Enbrel (Etanercept) and Kineret (Anakinra) and other late-stage products ... - East Bay Business Times,

XOMA Appoints Alan M. Solinger, MD as Vice President of Clinical ...  Jul 28, 2005
Amgen, he participated in the design of the clinical and commercial strategies for marketed products Enbrel(R) (Etanercept) and Kineret(R) (Anakinra), and for ... - Business Wire (press release),

Treating RA: Recent Evidence from the European League Against ...  Jul 25, 2005
These findings showing a greater infection risk are comparable to that previously reported with combination etanercept/anakinra. ... - Medscape (subscription)

Anakinra in the treatment of children with juvenile arthritis  May 27, 2005
To test this hypothesis, nine SoJIA patients received a drug, called Anakinra, which inactivated IL-1. Anakinra ( Kineret ) is a ... - Xagena.it,

Success in Treatment of Children with Juvenile Arthritis  May 28, 2005
To test this hypothesis, nine SoJIA patients received a drug, called Anakinra, which inactivated IL-1. Anakinra, marketed by Amgen, is a genetically engineered ... - Medical News Today,

New Phase III Data Shows Nearly Four Out Of Five Crohn's Patients ...  May 16, 2005
...could predispose them to infections. The combination of HUMIRA and anakinra is not recommended. TNF-blocking agents, including HUMIRA ... - Yahoo News

Crohn’s disease, efficacy of the treatment with Adalimumab  May 17, 2005
...predispose them to infections. The combination of Humira and Anakinra ( Kineret ) is not recommended. TNF-blocking agents, including ... - Xagena.it

Blocking IL-1 in systemic inflammation  May 2, 2005
In this issue, Pascual and colleagues show that blocking IL-1 activity with an IL-1 receptor antagonist (IL-1Ra, anakinra) resulted in convincing clinical and ... - Journal of Experimental Medicine

NPS Pharmaceuticals and Ventiv Health Announce the Launch of a ...  Mar 3, 2005
...(Nasdaq: VTIV), announced today that they have introduced a specialized sales team to promote Kineret(R) (anakinra), a biologic therapy owned by Amgen Inc ... - Canada NewsWire (press release),

NPS Pharmaceuticals and Ventiv Health Announce the Launch of a ...  Mar 3, 2005
...and Ventiv Health, Inc. , announced today that they have introduced a specialized sales team to promote Kineret(R) (anakinra), a biologic therapy owned by ... - ArriveNet (press release),

Psoriasis patients receiving HUMIRA® (adalimumab) achieved ...  Feb 22, 2005
...could predispose them to infections. The combination of HUMIRA and anakinra is not recommended. TNF-blocking agents, including HUMIRA ... - Medical News Today,